HSBC Holdings PLC set a CHF 205 price target on Roche Holding Ltd. (VTX:ROG) in a research note issued to investors on Tuesday morning. The firm currently has a sell rating on the healthcare company’s stock.

A number of other analysts have also recently commented on the stock. Goldman Sachs Group Inc set a CHF 335 price objective on shares of Roche Holding and gave the company a buy rating in a research report on Thursday, August 24th. Morgan Stanley set a CHF 260 price objective on shares of Roche Holding and gave the company a neutral rating in a research report on Friday, November 17th. J P Morgan Chase & Co restated a buy rating and issued a price objective on shares of Roche Holding in a research report on Monday, October 16th. Baader Bank set a CHF 231 price objective on shares of Roche Holding and gave the company a neutral rating in a research report on Thursday, October 19th. Finally, Kepler Capital Markets set a CHF 230 price objective on shares of Roche Holding and gave the company a neutral rating in a research report on Monday, September 11th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of CHF 261.78.

Shares of Roche Holding (ROG) opened at CHF 246.90 on Tuesday. Roche Holding has a 1 year low of CHF 218.30 and a 1 year high of CHF 273.

WARNING: This piece was first published by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/hsbc-holdings-plc-reiterates-chf-205-price-target-for-roche-holding-ltd-rog/1722716.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.